Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy

The Journal of Clinical Endocrinology and Metabolism
J SvenssonG Johannsson

Abstract

A retrospective comparison was performed between 1411 hypopituitary adults without GH replacement [mean age, 56.9 (sd 18.6) yr] and the normal population in terms of fatal and nonfatal morbidity. A similar prospective comparison was then made in 289 hypopituitary patients on long-term GH replacement [mean age, 47.6 (sd 14.8) yr; mean duration of GH treatment, 60 months]. In the 1411 hypopituitary patients without GH replacement, overall mortality (P < 0.001), and the rates of myocardial infarctions (P < 0.01), cerebrovascular events (P < 0.001), and malignancies (P < 0.001) were increased compared with the normal population. Colorectal cancer was the most common malignancy in this cohort (P < 0.001 vs. the background population). In the 289 hypopituitary patients on GH replacement, overall mortality and the rate of malignancies were similar to the normal population. In the hypopituitary adults on GH therapy, the rate of myocardial infarctions was lower than that in the background population (P < 0.05), and there was a tendency toward an increased rate of cerebrovascular events. In conclusion, overall mortality and the rate of myocardial infarctions were increased in hypopituitary patients without GH replacement. An increased ra...Continue Reading

Citations

Nov 2, 2006·Pituitary·M DogaA Giustina
Feb 13, 2013·Pituitary·Eva Marie ErfurthThomas Björk-Eriksson
Oct 7, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Anthony J Swerdlow
Apr 7, 2009·Nature Reviews. Gastroenterology & Hepatology·Paola LoriaAmedeo Lonardo
Dec 14, 2004·Hormone Research·M Pugeat
Dec 14, 2004·Hormone Research·A Heufelder
Dec 14, 2004·Hormone Research·A Leal Cerro
Feb 7, 2008·Hormone Research·Kirstine StochholmClaus Højbjerg Gravholt
Dec 8, 2009·The Journal of Clinical Endocrinology and Metabolism·Manuel H Aguiar-OliveiraRoberto Salvatori
Jan 2, 2013·Neurosurgery·Zhiyuan XuJason P Sheehan
Nov 7, 2007·European Journal of Endocrinology·Brian R Walker
Dec 17, 2011·Women's Health·Kate Maclaran, John C Stevenson
Jan 22, 2010·European Journal of Endocrinology·Charlotte HöybyeBeverly M K Biller
Apr 11, 2013·European Journal of Endocrinology·Natasha M Appelman-DijkstraNienke R Biermasz
Mar 26, 2008·European Journal of Endocrinology·Kirstine StochholmClaus Højbjerg Gravholt
Feb 23, 2013·European Journal of Endocrinology·Mariam ElbornssonJohan Svensson
Mar 30, 2012·European Journal of Endocrinology·Rolf C GaillardRoger Abs
Aug 30, 2013·European Journal of Endocrinology·Oskar Ragnarsson, Gudmundur Johannsson
Aug 13, 2013·European Journal of Endocrinology·Sandra Pekic, Vera Popovic
Aug 18, 2009·European Journal of Endocrinology·Johan Svensson, Bengt-Ake Bengtsson
Aug 18, 2009·European Journal of Endocrinology·Johan Verhelst, Roger Abs
Aug 18, 2009·European Journal of Endocrinology·Helena Filipsson, Gudmundur Johannsson
Aug 25, 2012·European Journal of Endocrinology·Kirstine StochholmClaus Højbjerg Gravholt
Jan 30, 2013·European Journal of Endocrinology·Whitney W WoodmanseeUNKNOWN GeNeSIS and HypoCCS International Advisory Boards
Jun 8, 2011·European Journal of Endocrinology·Christopher J ChildUNKNOWN HypoCCS International Advisory Board
Nov 11, 2008·Journal of Endocrinological Investigation·A GiustinaUNKNOWN European Neuroendocrine Association
Oct 10, 2013·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Mariam ElbornssonJohan Svensson
Jun 29, 2014·European Journal of Endocrinology·Cheol Ryong KuEun Jig Lee
May 14, 2014·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Annalisa DeodatiStefano Cianfarani
Feb 4, 2014·Medicina clínica·Juan J Díez, Fernando Cordido
Aug 12, 2014·Journal of Endocrinological Investigation·Y SimsekF Kelestimur
May 19, 2011·Wiener klinische Wochenschrift·Peter Herbert Kann
Apr 5, 2008·Der Internist·D Heutling, H Lehnert
Apr 18, 2008·Der Internist·M Faust, C J Strasburger
Sep 12, 2009·The American Journal of the Medical Sciences·Ebenezer A NyenweSolomon S Solomon
Aug 9, 2011·Otolaryngologic Clinics of North America·Paul LeeJerry R Greenfield
Aug 25, 2015·Endocrine Journal·Lara GiovanniniGiancarlo Balercia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.